Type II variation for application Roszdravnadzor-2021-0079. Type II variation: New Dosage Strength for Brextanib — critical change

Variation Number
Roszdravnadzor-2021-0079-V379
Type
Type II
Status
Blocked
Fee
€8,583
Submitted
2024-03-11
Approved
—
Description

Type II variation: New Dosage Strength for Brextanib — critical change